
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
Elma Aflaki, Wendy Westbroek, Ellen Sidransky
Neuron (2017) Vol. 93, Iss. 4, pp. 737-746
Open Access | Times Cited: 148
Elma Aflaki, Wendy Westbroek, Ellen Sidransky
Neuron (2017) Vol. 93, Iss. 4, pp. 737-746
Open Access | Times Cited: 148
Showing 1-25 of 148 citing articles:
Biological Functions of Autophagy Genes: A Disease Perspective
Beth Levine, Guido Kroemer
Cell (2019) Vol. 176, Iss. 1-2, pp. 11-42
Open Access | Times Cited: 2281
Beth Levine, Guido Kroemer
Cell (2019) Vol. 176, Iss. 1-2, pp. 11-42
Open Access | Times Cited: 2281
Lysosomes as dynamic regulators of cell and organismal homeostasis
Andrea Ballabio, Juan S. Bonifacino
Nature Reviews Molecular Cell Biology (2019) Vol. 21, Iss. 2, pp. 101-118
Closed Access | Times Cited: 1084
Andrea Ballabio, Juan S. Bonifacino
Nature Reviews Molecular Cell Biology (2019) Vol. 21, Iss. 2, pp. 101-118
Closed Access | Times Cited: 1084
Lysosomal storage diseases
Frances M. Platt, Alessandra d’Azzo, Beverly L. Davidson, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 794
Frances M. Platt, Alessandra d’Azzo, Beverly L. Davidson, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 794
Lysosomes as a therapeutic target
Srinivasa Reddy Bonam, Fengjuan Wang, Sylviane Muller
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 12, pp. 923-948
Open Access | Times Cited: 606
Srinivasa Reddy Bonam, Fengjuan Wang, Sylviane Muller
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 12, pp. 923-948
Open Access | Times Cited: 606
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Barry Boland, Wen H. Yu, Olga Corti, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 660-688
Open Access | Times Cited: 467
Barry Boland, Wen H. Yu, Olga Corti, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 660-688
Open Access | Times Cited: 467
Glucocerebrosidase and its relevance to Parkinson disease
Jenny Do, Cindy E. McKinney, Pankaj Sharma, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 249
Jenny Do, Cindy E. McKinney, Pankaj Sharma, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 249
α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Michael X. Henderson, John Q. Trojanowski, Virginia M.‐Y. Lee
Neuroscience Letters (2019) Vol. 709, pp. 134316-134316
Open Access | Times Cited: 228
Michael X. Henderson, John Q. Trojanowski, Virginia M.‐Y. Lee
Neuroscience Letters (2019) Vol. 709, pp. 134316-134316
Open Access | Times Cited: 228
Emptying the stores: lysosomal diseases and therapeutic strategies
Frances M. Platt
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 2, pp. 133-150
Open Access | Times Cited: 222
Frances M. Platt
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 2, pp. 133-150
Open Access | Times Cited: 222
LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri, Michel Brahic, Luc Bousset, et al.
Acta Neuropathologica (2019) Vol. 137, Iss. 6, pp. 961-980
Open Access | Times Cited: 164
Gregor Bieri, Michel Brahic, Luc Bousset, et al.
Acta Neuropathologica (2019) Vol. 137, Iss. 6, pp. 961-980
Open Access | Times Cited: 164
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods
Vinod Udayar, Yu Chen, Ellen Sidransky, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 184-199
Open Access | Times Cited: 131
Vinod Udayar, Yu Chen, Ellen Sidransky, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 184-199
Open Access | Times Cited: 131
Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
S. Pablo Sardi, Jesse M. Cedarbaum, Patrik Brundin
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 684-696
Open Access | Times Cited: 157
S. Pablo Sardi, Jesse M. Cedarbaum, Patrik Brundin
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 684-696
Open Access | Times Cited: 157
Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult
Michael X. Henderson, Samantha F. Sedor, Ian McGeary, et al.
Neuron (2019) Vol. 105, Iss. 5, pp. 822-836.e7
Open Access | Times Cited: 110
Michael X. Henderson, Samantha F. Sedor, Ian McGeary, et al.
Neuron (2019) Vol. 105, Iss. 5, pp. 822-836.e7
Open Access | Times Cited: 110
The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress
Elizabeth B. Moloney, Alyssa Moskites, Eliza J. Ferrari, et al.
Neurobiology of Disease (2018) Vol. 120, pp. 1-11
Open Access | Times Cited: 103
Elizabeth B. Moloney, Alyssa Moskites, Eliza J. Ferrari, et al.
Neurobiology of Disease (2018) Vol. 120, pp. 1-11
Open Access | Times Cited: 103
Neurodegeneration and the ordered assembly of α-synuclein
Maria Grazia Spillantini, Michel Goedert
Cell and Tissue Research (2017) Vol. 373, Iss. 1, pp. 137-148
Open Access | Times Cited: 95
Maria Grazia Spillantini, Michel Goedert
Cell and Tissue Research (2017) Vol. 373, Iss. 1, pp. 137-148
Open Access | Times Cited: 95
Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease
Yutaka Oji, Taku Hatano, Shin-Ichi Ueno, et al.
Brain (2020) Vol. 143, Iss. 4, pp. 1190-1205
Open Access | Times Cited: 95
Yutaka Oji, Taku Hatano, Shin-Ichi Ueno, et al.
Brain (2020) Vol. 143, Iss. 4, pp. 1190-1205
Open Access | Times Cited: 95
The influence of environment and origin on brain resident macrophages and implications for therapy
Mariko L. Bennett, F. Chris Bennett
Nature Neuroscience (2019) Vol. 23, Iss. 2, pp. 157-166
Closed Access | Times Cited: 94
Mariko L. Bennett, F. Chris Bennett
Nature Neuroscience (2019) Vol. 23, Iss. 2, pp. 157-166
Closed Access | Times Cited: 94
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
Tracy Cole, Hien Zhao, Timothy J. Collier, et al.
JCI Insight (2021) Vol. 6, Iss. 5
Open Access | Times Cited: 94
Tracy Cole, Hien Zhao, Timothy J. Collier, et al.
JCI Insight (2021) Vol. 6, Iss. 5
Open Access | Times Cited: 94
How we manage Gaucher Disease in the era of choices
Shoshana Revel‐Vilk, Jeff Szer, Atul Mehta, et al.
British Journal of Haematology (2018) Vol. 182, Iss. 4, pp. 467-480
Open Access | Times Cited: 92
Shoshana Revel‐Vilk, Jeff Szer, Atul Mehta, et al.
British Journal of Haematology (2018) Vol. 182, Iss. 4, pp. 467-480
Open Access | Times Cited: 92
Modeling Parkinson’s Disease in Drosophila: What Have We Learned for Dominant Traits?
Yulan Xiong, Jianzhong Yu
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 87
Yulan Xiong, Jianzhong Yu
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 87
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
Michel Peterschmitt, Nigel P.S. Crawford, Sebastiaan J.M. Gaemers, et al.
Clinical Pharmacology in Drug Development (2020) Vol. 10, Iss. 1, pp. 86-98
Open Access | Times Cited: 86
Michel Peterschmitt, Nigel P.S. Crawford, Sebastiaan J.M. Gaemers, et al.
Clinical Pharmacology in Drug Development (2020) Vol. 10, Iss. 1, pp. 86-98
Open Access | Times Cited: 86
Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review
Shoshana Revel‐Vilk, Maria Fuller, Ari Zimran
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7159-7159
Open Access | Times Cited: 78
Shoshana Revel‐Vilk, Maria Fuller, Ari Zimran
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7159-7159
Open Access | Times Cited: 78
Novel targeted therapies for Parkinson’s disease
Theodora Ntetsika, Paraskevi-Evita Papathoma, Ioanna Markaki
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 78
Theodora Ntetsika, Paraskevi-Evita Papathoma, Ioanna Markaki
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 78
Direct activation of microglia by β-glucosylceramide causes phagocytosis of neurons that exacerbates Gaucher disease
Takashi Shimizu, Charles R. Schutt, Yoshihiro Izumi, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 307-319.e8
Open Access | Times Cited: 27
Takashi Shimizu, Charles R. Schutt, Yoshihiro Izumi, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 307-319.e8
Open Access | Times Cited: 27
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
Myung Jong Kim, Sohee Jeon, Lena F. Burbulla, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. 11, pp. 1972-1988
Open Access | Times Cited: 66
Myung Jong Kim, Sohee Jeon, Lena F. Burbulla, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. 11, pp. 1972-1988
Open Access | Times Cited: 66